I agree. Just about every otc experienced the big January spike but Alkame has held its ground better than almost all of them. The pr's they are putting out aren't speculation or fluff. They are for signed contracts, some worth millions. They are for new contracts with companies that have products on the shelves already. They are for formulating new products for all manner of new companies, whose product they will also produce and bottle. Not the sort of things you file with the SEC if they are fraudulent. These are indisputable facts, not opinion like so many negative assessments of this company.
As far as a revers split goes, having recently raised the share structure there was no big selloff as is typical when that happens, and 80% of the increased shares are still restricted, so they would logically release those long before any revers split happened.
I am holding long and strong.
$ALKM for the win.
Market Data 
Markets 
AI
